STING has been identified in 2008 as an endoplasmic reticulum receptor that induces innate immune responses (29) and is currently a hot topic in several fields including cancer immunotherapy (30), vaccines (31) and autoimmunity (32, 33). Here, STING1 is linked to cancer.